Journal of Clinical Pathology 2007;60:283-289
ORIGINAL ARTICLE
Receptor-activated Smad localisation in Bleomycin-induced pulmonary fibrosis
Department of Pharmacology, Tsukuba Research Laboratories, GlaxoSmithKline, Tsukuba, Ibaraki, Japan
Correspondence to:
Correspondence to:
Dr S Asano
Department of Pharmacology, Tsukuba Research Laboratories, GlaxoSmithKline, 43 Wadai, Tsukuba, Ibaraki 300-4247, Japan;satoshi.asano{at}gsk.com
Background: Recent advances in fibrosis biology have identified transforming growth factor (TGF)-ß type I receptor-mediated activation of Smads as playing a central part in the development of fibrosis. However, to date, there have been few studies that examined the localisation and distribution of receptor-activated Smads protein (R-Smads: Smad2 and 3) during the fibrosis progression.
Aims: To histopathologically assess the time-course change of the localisation and distribution of the Smads protein in pulmonary fibrosis.
Methods: Pulmonary fibrosis was induced by intranasal injection of bleomycin (0.3 U/mouse). Lungs were isolated 2, 5, 7, 9 and 14 days after bleomycin treatment. Histological changes in the lungs were evaluated by haematoxylin-eosin stain or Massons trichrome stain, and scored. TGF-ß1, Smad3 and phosphorylated Smad2 localisations in lung tissues were determined by immunohistochemistry.
Results: The bleomycin treatment led to considerable pulmonary fibrotic changes accompanied by marked increase in TGF-ß1 expression in infiltrating macrophages. With the progression in fibrosis (day 714), marked increases in Smad3-positive and pSmad2-positive cells were observed. There were intense Smad3-positive and pSmad2-positive signals localised to the nuclei of the infiltrating macrophages and to type II epithelial cells, and less intense signals in fibroblasts and hyperplastic alveolar/bronchiolar epithelial cells.
Conclusions: The time-course data of TGF-ß1 and R-Smads indicate that progressive enhancement of TGF-ß1 signalling via R-Smad is activated in the process of fibrosis progression.
Abbreviations: ECM, extracellular matrix; TGF, transforming growth factor
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Zhou, Y., Koli, K., Hagood, J. S., Miao, M., Mavalli, M., Rifkin, D. B., Murphy-Ullrich, J. E.
(2009). Latent Transforming Growth Factor-{beta}-Binding Protein-4 Regulates Transforming Growth Factor-{beta}1 Bioavailability for Activation by Fibrogenic Lung Fibroblasts in Response to Bleomycin. Am. J. Pathol.
174: 21-33
[Abstract] [Full Text] -
Rong, J. X., Qiu, Y., Hansen, M. K., Zhu, L., Zhang, V., Xie, M., Okamoto, Y., Mattie, M. D., Higashiyama, H., Asano, S., Strum, J. C., Ryan, T. E.
(2007). Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet-Fed Mice and Improved by Rosiglitazone. Diabetes
56: 1751-1760
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
